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Abstract 
 
Aims TOur study aimed to assess and analyze the burden of vision loss due to eye diseases 
in China between 1990 and 2015, and also to predict the burden in 2020. 
 
Methods Data from the Global Burden of Diseases, Injuries, and Risk Factors Study 2015 
(GBD 2015) were used. The main outcome measureements were pPrevalence and Years 
lived with disability (YLDs) . The Number, Rate and Percentage in Prevalence and YLDs for 
vision loss due to Cataract, Glaucoma, Macular degeneration, Other vision loss, Refraction 
and accommodation disordersRefractive error and Trachoma were computed and analyzed. 
 
Results Prevalences for theseall the eye diseases increasedhave been increasing steadily 
from 1990 to 2015, and will increase till 2020. From 1990 to 2015, the most commonleading 
eye disorder was Refraction and accommodation disorders. Comparinged with those in 1990, 
the proportion of the total vision loss burden due to eye disease among those under the age 
of 14 years in 2015 decreased under the age of 14 years, increased while that above the age 
of 15 years increased, especially increased substantiallymost prominently above the age of 
50 years. China ranked 10th when comparing YLDs for vision loss due to eye diseases in 
China with that of the the other 18 member countries members of the G20. (the 20th member 
is the European Union). Age-standardized YLD Rates for vision loss due to eye diseases 
declined in the other all the 19 countries, except for that in China. The bBurden from vision 
loss due to eye diseases ranked 12th and 11th among all the causes ofthat can lead to health 
loss in China in 1990 and 2015 respectively. 
 
Conclusion Alone among major economies, For the past 25 years, China has 
experiencedhad less control over the vision loss burden from an increase in the burden of 
age-standardized vision loss from eye disease over the last two decadess. In the future, 
China maywill expect a growinglarger burden of vision loss due tobecause of population 
growth and ageing. 
 
Funding Ministry of Health of the Ppeople’s Rrepublic of China (Grant Number 201002019). 
  
China has the world’s largest population, over 1.406 billion, accounting for nearly 20% of the 
earth’s inhabitants.1 China has made enormous strides in improving health in the past few 
decades: life expectancy at birth has steadily increased and the under-5 mortality rate has 
greatly fallen sharply. 2-4 At the same time, more needs to be done to further enhance the 
quality of the longer lives of China’s citizens. A comprehensive assessment of current and 
expected disease burdens can help to inform China’s health reform efforts, and provide 
evidence to support long-range strategies. 
 
Vision loss due to eye diseases is a major health problem, greatly affecting quality of life. 
Globally as of 2015, 34·3 million people weare blind, an additional 24·3 million hdave severe 
vision impairment, 214 million hadave moderate vision impairment, and 663 million hadve 
near vision impairment in 2015.5 Vision loss is the third largest cause of impairment after 
anaemia and hearing loss, .6 but tThe burden of vision loss in China remainsis still  unclear 
yet. The GGlobal Burden of Diseases Study is the result of a worldwide collaboration aimed at 
quantifying various health metrics of loss to diseases and injuries. These metrics enable 
comparison of health data across boundaries of geography and time in a way that is more 
comprehensive and internally consistent than possible with previous data sources.6-8 
 
Our study aimsed to quantify the burden of vision loss due to various eye diseases in China 
from 1990 to 2015 using the Global Burden of Diseases, Injuries, and Risk Factors Study 
2015 (GBD 2015), and also to predict the burden in 2020.    
 
  Methods 
 
Data from the Global Burden of Diseases, Injuries, and Risk Factors Study 2015 (GBD 2015) 
from 1990 to 2015 were used to analyze the burden of vision loss due to eye diseases in 
China.7 We searched and extracted related data from a website database 
(http://ghdx.healthdata.org), which was set up and shared by the Global Burden of Disease 
Study group. Details on the data, approaches to enhancing data quality and comparability, 
and statistical modeling and metrics for the GBD 2015 have been reported previously.6-9 In 
brief, the GBD study team collected data from household surveys archived in the Global 
Health Data Exchange, sources suggested by in-country experts, and surveys identified in 
major multinational survey data catalogues and Ministry of Health and Central Statistical 
Office websites. Then they estimated incidence and prevalence of various conditions by age, 
sex, cause, year, and geography using a wide range of updated and standardised analytical 
procedures, including s. The procedure includes several steps such as data screening, data 
adjustment, DisMod-MR 2.1 estimation, and injury modelling strategies.y, and so on. Then 
tThe GBD investigatorsstudy used numerous metrics to report results on health loss related to 
specific causes of disease and injury: deaths and death rates, years of life lost due to 
premature mortality (YLLs), years lived with disability (YLDs), and disability-adjusted life-years 
(DALYs).2,9 
 
The main outcome measure of our study were pPrevalence and YLDs, and the Numbers, 
Rates and Percentages of Prevalence and YLDs forassociated with the vision loss burden 
due to various eye diseases were assessed and analyzed. YLDs refer to years of life lived 
with any short-term or long-term health loss, which were equal to the prevalence of the eye 
disease multiplied by its associated disability weights.10 GBD 2013 included new data for 
disability weights, which quantify the severity of health loss associated with a particular 
disease.8 Disability weights uses numbers on a scale from 0 to 1 that represents the severity 
of health loss associated with a particular health state.8,10-12 The severity of health loss was 
based on surveys of the general public in five countries (Bangladesh, Indonesia, Peru, 
Tanzania, and the USA) and an open internet survey.8,10-12 These disability weights were used 
to calculate the YLDs for various diseases. The YLD Rates were calculated by dividing the 
number of years of life lost by the relevant population.10-12 The Age-adjusted Rates were 
calculated using the WHO 2000-2025 World standard population, which excluded the effects 
of total population size and age structure.8,9,12 The Percentage fors in YLDs were calculated 
as the number of years lived with disabilitylost due to a specific disease divided by the total 
number of years lived with disability of life lost for all diseases.  
 
The following six ocular diseases were listed in the GBD 2015: Cataract, Glaucoma, Macular 
degeneration, Trachoma, Refraction and accommodation disorders and Other vision loss.7 
The other vision loss category included a total of 57 eye conditions.13 The changing trends of 
the burden of vision loss over time and with age were investigated. We also compared the 
burden of vision loss in China with the burden of other diseases and with the burden of vision 
loss in other countries.  
 Results 
 
 
Figure 1: Prevalence for various eye diseases from 1990 to 2020 in China.  
 
From 1990 to 2015, the most common leading eye disorder in China was Refraction and 
accommodation disorders whose prevalences were much higher than those of other eye 
diseases (fFigure 1)., while T the second most commonleading cause was Cataract, followed 
by Other vision loss. Prevalences for Macular degeneration and Glaucoma were similar, with 
Glaucoma being more common a bit more before 2005 and Macular degeneration being a bit 
more common after 2005. The pPrevalences for Trachoma was thewere lowest. Prevalences 
for all includedthe eye diseases have been increasing steadily from 1990 to 2015, and willare 
projected to  increaserise until till 2020. We further analyzed Age-standardized Pprevalence 
Rrates. Prevalence Rates for Refraction and accommodation disorders, Cataract and Other 
vision loss almost remained essentially unchanged, w. While  Prevalence Rrates for Macular 
degeneration and Glaucoma increased slightly slightly went up and those for Trachoma fell 
considerablygreatly went down.  
 
 
  
 
YLDs: years lived with disability 
 
Figure 2: Distribution of pPrevalence for various eye diseases and YLDs from vision loss due 
to eye diseases in China, by age, 1990 and 2015 (figure left: Prevalence; figure right: YLDs) 
 
Comparing with those in 1990, the proportion of the totalThe  vision loss burden due to eye 
disease in 2015 decreased between 1990 and 2015 for those under the age of 14 years, and 
increased among those above the age of 15 years and above, with the most notable 
especially increased substantially increases occurring atabove the age of 50 years and above 
(Ffigure 2). The bAbove the age of 50 years, burden of vision loss due to every individual eye 
disease, which included Cataract, Glaucoma, Macular degeneration, Trachoma, Refraction 
and accommodation disorders and Other vision loss, increased from 1990 to 2015 among 
those 50 and above, . Twith the relative contributions of individual eye diseases to the overall 
burden changeingd little over this time between 1990 and 2015. There was lack of data on 
vision burden from Cataract and Glaucoma in the 0 to 14 age range. Refraction and 
accommodation disorders accounted for the majority of the burden of vision loss in all age 
groups both in 1990 and in 2015.  
 
  
Table 1: All-age YLDs and aAge-standardized YLD rRates for vision loss due to various eye 
diseases in 1990 and 2015 for 19 member countries of the Group of 20G20 (The 20th member 
is the European Union) 
 
Country name 
All-age YLDs 
TotalNumber in 
1990 
All-age YLDs in 2015 
Age-
standardised 
YLD Rate in 
1990 
( per 100 000) 
Age-
standardised 
YLD in 2015 
TotalNumber Rank Rate 
( per 100 000) 
Rank 
Argentina 60599.8 83408.9  16 200.2 184.3 13 
Australia 25155.6 40733.2  19 144.1 137.9 15 
Brazil 304261.5 571429.5  5 304.6 295.4 8 
Canada 32291.3 50606.0  18 112.5 111.4 19 
China 2047612.3 3800391.3  2 241.4 257.8 10 
France 96785.4 127394.3  14 143.2 134.4 16 
Germany 162720.4 198186.4  10 164.1 152.9 14 
India 2977270.0 5358196.6  1 574.4 539.0 1 
Indonesia 451601.8 700590.1  3 416.1 368.1 5 
Italy 143658.6 192572.7  11 207.3 193.9 12 
Japan 364310.7 566869.1  6 268.8 261.3 9 
Mexico 218669.0 424234.9  8 405.3 405.1 3 
Russia 507649.4 615370.6  4 327.9 317.0 6 
Saudi Arabia 38520.6 78733.8  17 420.4 371.0 4 
South Africa 106195.5 176087.8  12 430.5 420.7 2 
South Korea 90642.7 150444.5  13 267.9 254.0 11 
Turkey 137962.9 223080.6  9 348.7 314.8 7 
United 
Kingdom 99078.5 114855.4  15 142.2 132.7 17 
United States 313948.2 444171.7  7 116.5 115.0 18 
YLDs: years lived with disability 
 
We compared YLDs for vision loss due to eye diseases in China with that of the other 18 
member countries of the G20 (the 20th member is the European Union) (tTable 1). We found 
that, comparing with that in 1990,  aAll-age YLDs for the burden of vision loss in 2015  
increased in all the 19 countries between 1990 and 2015in different degrees. In 2015, China 
ranked 2nd for aAll-age YLDs, only behind only India. In terms of the aAge-standardized YLD 
rRates for vision loss burden, China ranked 10th., behind India, South Africa, Mexico, Saudi 
Arabia, Indonesia, Russia, Turkey, and Brazil, and ahead of countries such as Italy, Argentina, 
Germany, Australia, France, United Kingdom, United States, and Canada, while very similar 
to Japan and South Korea. Age-standardized YLD rRates for vision loss due to eye diseases 
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 declined between 1990 and 2015 with varying degrees in all the 19 countries, except for that 
in China.  
  
Table 2: Top 20 causes of aAll-age YLDs and Age-standardised YLD rRates in China in 1990 
and 2015 
YLDs: years lived with disability 
 
In 1990 and 2015, the burden from vision loss due to eye diseases ranked 12th and 11th 
respectively among all the causes ofthat can lead to health loss (Ttable 2). The rank of vision 
loss burden remained quite stable compared with burdens from other diseases in China. Most 
burdens from various causes increased in 2015 compared with those in 1990, except for Iron-
deficiency anemia and Ascariasis. Compareding with that in 1990, the All-age YLD total vision 
loss burden increased greatly in 2015 with percentage change as increased by 85.6%, the 
fifth-highest such increase in All-age YLD Number between 1990 and 2015. The percentage 
change for it ranked 5th. The While Age-standardised YLD rRate for the vision loss burden 
Cause name 
All Ages YLD 
in 1990 
All Ages YLD 
in 2015 
Percentage change 
in All ages YLD 
Number between 
1990 and 2015 (%) 
Age-
standardis
ed YLD 
Rate in 
1990 
Age-
standardis
ed YLD 
Rate in 
2015 
Percentage change 
in Age-standardised 
YLD Rate between 
1990 and 2015 (%) TotalNumb
er Rank Number Rank 
Lower back pain 6824391.5  1 10445627.6  1 53.1 696.0 655.8 -5.8  
Neck pain 4948621.3  3 9297530.8  2 87.9 514.9 556.1 8.0  
Age-related and other hearing 
loss 
4784037.3  4 8555665.2  3 78.8 595.9 581.4 -2.4  
Major depressive disorder 4565074.8  5 6681222.8  4 46.4 425.4 426.8 0.3  
Diabetes mellitus 2793655.8  10 5884165.5  5 110.6 307.0 360.6 17.5  
Other musculoskeletal 
disorders 3846366.6  6 5866966.2  6 52.5 361.7 371.3 2.7  
Iron-deficiency anemia 5615397.3  2 4829908.3  7 -14.0 456.5 413.4 -9.4  
Schizophrenia 2855975.1    9 4543735.7  8 59.1 262.9 274.1 4.3  
Migraine 3057968.1  8 4127002.9  9 35.0 265.6 265.6 0.0  
Anxiety disorders 3208267.9  7 3804590.5  10 18.6 276.6 267.3 -3.4  
Vision loss due to eye 
diseases 2047612.3  12 3800391.3  11 85.6 241.4 257.8 
6.8  
Osteoarthritis 1477761.2  14 3602698.2  12 143.8 190.0 218.5 15.0  
Chronic obstructive pulmonary 
disease 
2634071.1  11 2772680.8  13 5.3 316.5 184.4 -41.7  
Dysthymia 1435242.5  15 2300178.5  14 60.3 143.0 143.2 0.1  
Drug use disorders 1291166.0  16 2156146.9  15 67.0 100.6 142.8 41.9  
Road injuries 726933.0  23 1831072.7  16 151.9 74.2 114.8 54.7  
Falls 1056459.5  19 1606745.0  17 52.1 107.4 105.9 -1.4  
Food-borne trematodiases 1237355.3  17 1527471.4  18 23.5 103.9 99.2 -4.5  
Bipolar disorder 1074950.0  18 1410904.6  19 31.3 90.8 91.2 0.4  
Alcohol use disorders 929596.0  20 1363909.7  20 46.7 80.4 85.0 5.7  
Ascariasis 1891992.3  13 42722.1  29 -97.7 164.4 3.0 -98.2  
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 changed much less between 1990 and 2015, with the percentage change asincreasing by 
only 6.8%, which was the 6th-highest increase. The range of percentage change in Age-
standardised YLD Rate for top 20 causes was from 54.7% to -98.2% between 1990 and 
2015, and the percentage change for vision loss burden ranked 6th.  
Formatted: Superscript
 Discussion 
 
Previous studies have usually focused on the prevalence of eye diseases alone to evaluate 
the burden of vision loss. Our study aimed to investigate the vision loss burden in China using 
both pPrevalence and YLDs, which enables the comparison of burden from vision loss with 
those from other diseases and in other countries. The results of our study can provide an 
overview understanding of vision loss burden in China for the first time. 
 
OurThe findingsresults indicated that by far the burden of vision loss in China was dominated 
by Refraction and accommodation disorders, which is consistent with findings in other 
countries in the world.14-18 Considering that most Refraction and accommodation disorders 
can be safely and inexpensively corrected, greater efforts should be made to tackle this 
problem. ‘VISION 2020: the Right to Sight’ aims to eliminate avoidable blindness by the year 
2020. Refraction and accommodation disorders mostly belong to avoidable blindness and 
should be considered as a priority have the priority to be taken care of. The second- leading 
cause of vision loss burden was Cataract, which is also the. Cataract was the leading cause 
for blindness in China.16,19 China’s cataract surgery rate (CSR) in XXX was 1072/million/year, 
which was not only lower than those in developed countries, but also lower than rates for 
other countries in the region with lower per capita incomes than China, includingthose in 
Thailand, Vietnam, Laos, Kampuchea, and the Philippines and other developing countries.19 
Tackling Cataract is still a great challenge in China, in part due to inadequate training 
opportunities for young surgeons.  
 
Age-standardized pPrevalence rRates revealcan show the truereal burden of eye disease, s 
excluding the effect of population size and age structure. For the past 25 years, aAge-
standardized pPrevalence rRates for Refraction and accommodation disorders, Cataract and 
Other vision loss almost remained virtually unchanged, which iwas particularly concerning, 
given that these conditions are eminently treatable. Of even greater concern is the fact thatIt 
was even worse that aAge-standardized PPrevalence RRates for Macular degeneration and 
Glaucoma actually gradually increased over this period. Little progress has been made in 
controlling the prevalence rate of these eye diseases. Due toCombined with population 
growth and aging, the aAll-age pPrevalences for all majorthe eye diseases in China have 
been dramatically increasing fromincreased dramatically between 1990 andto 2015, and 
willare predicted to increase untiltill 2020. Trachoma was the one exception, whose age-
adjusted rate greatly decreased. China has made remarkable success in eradicating 
Trachoma. This is consistent with the fact that WHO has recently certified China free of active 
trachoma.  
 
When we studied the vision loss burden by age group, it was encouraging that in population 
this fell between 1990 and 2015 agedin the 0 to -14- year group, it decreased from 1990 to 
2015. But in the age groups above 15 years, the vision loss burden has increased for the past 
25 years over this period, particularly among those. Especially above the age of 50 years, the 
burden substantially increased. Since the family planning policy began to take into effect from 
the beginning of 1970s and became one of China's basic state policies in 1982, significant 
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 attention has been paid to the children because of one-child only.The observed progress 
among younger ages may be due to China’s one-child policy, promulgated since the 1970s, 
and the resulting attention paid by families to the well-being of children. Meanwhile, due in 
part to the one child policy, China has stepped into an aging population rapidly. China has 
made great efforts to control the population growth. Some experts predicted that in 2023, the 
population will stop growing in China.20 But China has faced with severe population ageing 
and the situation will be more and more serious in the future. According to the classification 
criteria of the United Nations in 1956, when the number of people aged 60 years and over 
reaches 10% or the number of people aged 65 years and over reaches 7% of the population, 
the population is ageing.21 In 1990, the population of China was over 1143 million, with 8.48% 
of the population were over 60 years old and 5.51% were over 65 years old.20But this policy 
has also led to the rapid aging of China’s population, with the proportion aged 65 years and 
above growing from 5.51% in 1990 to  In 2015, the population of China was over 1406 
million, and 16.1% of the population was above 60 years old and 10.5% above 65 years oldin 
2015.20 Most vision loss diseases common causes of vision loss are age related, such as 
cataract, glaucoma and macular degeneration. The ageing population plays a significant 
impact on therole in the increasing burden of vision loss,  and much more attention should 
be paid to population ageing. Nand national policy should give priority for the aged to control 
eye diseasesto controlling such eye diseases of aging. 
 
The burden of vision loss in China was somewhat less than a little better than that in India 
and was worse than those in other member countries of the G20. This was to be at was 
expected, taking China’s largethe huge population into account. Age-standardized YLDs Rate 
of vision loss burden in China ranked 10th among the G20 countries, higher than some 
developed countries and lower than some less developed countries. That is also acceptable. 
However, iIt is worth noting that China was the only country whose Aage-standardized YLD 
rRates for vision loss in 2015 was higher than that in 1990. ThisIt is quite concerning, assince 
it shows that there has been little  was hardly any progression in controlling vision loss 
overfor the past 25 years. Without considering the population growth and ageing, the vision 
loss burden in China has not only failed to decrease, but increased. ThisIt should serve as be 
a wakeup call for both the eyecare providers eye doctors and healththe policy makers.  
 
Comparing to 1990, the All-age YLDs from vision loss burden increased 85.6% in 2015. 
Meanwhile, the Age- standardized YLDs Rate for it increased with percentage change of 
6.8%. It indicated that the difference of vision loss burden was majorly due to population 
growth and ageing and minorly due to less control of eye diseases. The burden of vision loss 
due to eye diseases ranked 12th in 1990 and 11th in 2015 among all the causes that can affect 
people’s healthcauses of health loss in China. The real burden of vision loss mayight be even 
worse,  because as some diseases which also damage visual function and lead to blindness, 
such as diabetic retinopathy, were not included in our study. For example, diabetic retinopathy 
was not evaluated separately in GBD 2015. Thus we could not investigate the vision loss 
burden from diabetic retinopathy. Furthermore, rarer causes of vision loss among children 
such as congenital cataract and , congenital glaucoma in Children have not been were not 
investigated in the GBD study. ThisIt is understandable, since very few population-based 
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 studies have included younger age groups, thus it might bemaking it difficult to establish the 
precise estimates.5 The burden of vAnd the vision loss couldmay be underestimatedstated 
due to the scarcity of data for because the data for children aged younger than 15 years are 
scarce.2,5  
 
This study has several limitations. Although the GBD Vision Loss Expert Group has tried their 
bestmade every effort to collect all the published and unpublished data,5 the quantity and 
quality of data available are still limited, which. Differences in the quantity and quality of data 
entered into the system  could affect the accuracy of the estimated burden. However, it is 
persuasive that the data availability in China has similar levels to those in many developed 
countries.2,3,5 Also, the estimatedevaluation of vision loss burden in GBD 2015 might not be 
may be incomplete due to failure to include certain diseases, as noted above.. Vision loss 
from several other diseases have not been included as we described previously. The GBD 
studies need some improvements. But it is by far Despite these limitations, GBD remains the 
most standardized and accurate system available to make comparisons, especially when we 
aim to assess disease burdens across times and places, and across different diseases and 
injuries.    
 
In summary, this study demonstrates that progress in controlling vision loss from eye disease 
in China has been sub-optimal over the last 25 years. quantitatively evaluated the burden of 
vision loss due to eye diseases in China. It is crucial to comprehend how well our health 
system was tackling these problems. It is particularly concerning that for the past 25 years, 
we had less control over the vision loss burden from eye diseases. In the future, China will 
face more serious population ageing as well as population growth and China willand should 
thus expect expect a largerto encounter a growing burden of vision loss. Effective policies and 
measures to address this rising burden are of great priority for the goals of Vision 2020: The 
Right to Sights.      hould be a national priority. 
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